期刊文献+

大孔吸附树脂法制备无患子皂苷及其抑菌活性表征 被引量:13

Investigation on the Process of Sapindus Saponin Purified with Macroporous Adsorption Resin and Screening of Its Bacteriostasis
原文传递
导出
摘要 目的:制备无患子皂苷抑菌活性部位。方法:以无患子皂苷的洗脱率、精制度为指标,考察大孔吸附树脂对无患子皂苷的吸附性能和洗脱参数,并采用管碟法评测各洗脱部位抑菌活性强弱,以确证无患子皂苷制备工艺的合理性。结果:13.6mL无患子皂苷样品液(生药0.01g/mL)上大孔吸附树脂柱(Φ15mm×H90mm,干重2.5g),用蒸馏水、30%乙醇、70%乙醇各3BV依次洗脱,抑菌活性部位无患子皂苷富集于70%乙醇洗脱液中。结论:通过大孔吸附树脂富集与纯化,无患子皂苷洗脱率为93.8%,精制度为250.1%,为无患子抑菌活性部位的开发提供了物质保障,亦为其它皂苷类化合物的纯化工艺研究提供了实验参考。 Objective:To study the technological parameters of the purification process of saponins with macroporous adsorption resin. Methods: The adsorptive characteristics and elutive parameters of the process were studied by taking the elutive and purified ratio of saponins as markers. Bacteriostasis activity of each parts eluted was evaluated by the mean of cup-plate method. Results: 13.6 mL of the extraction of sapindus saponin (crude drugs 0.01 g/mL) was purified with a column of macroporous adsorption resin (Φ15 mm×H90 mm,dry weight 2.5 g) and washed with 3BV of distilled water, then eluted with 3BV of 30% ethanol and 3BV of 70% ethanol, most of saponins were collected in the 70% ethanol. Conclusion: With macroporous adsorption resin adsorbing and purifying, the elutive ratio of saponins was 93.8% and the purity reached 250.1%. So this process of applying macroporous adsorption resin to adsorb and purify saponins is feasible, and supplies reference to the purification of other types of saponin.
出处 《中药材》 CAS CSCD 北大核心 2010年第2期267-272,共6页 Journal of Chinese Medicinal Materials
关键词 大孔吸附树脂 纯化 无患子皂苷 抑菌活性 Macroporous adsorption resin Purification Sapindus saponin Bacteriostasis
  • 相关文献

参考文献9

二级参考文献50

  • 1张银娣,沈建平,王幼林,刘小浩,张晓林,李德兴.黄芪苷抗生物氧化作用的研究[J].中药药理与临床,1991,7(6):14-17. 被引量:42
  • 2谢飞,何思平,张莉.黄芪的药理研究进展[J].云南医药,1994,15(2):157-159. 被引量:19
  • 3金继曙,都述虎,种明才.用大孔吸附树脂分离白芍总甙[J].中国中药杂志,1994,19(1):31-31. 被引量:41
  • 4冯孝章 陈玉武(等).天麻化学成分的研究[J].化学学报,1979,37(3):175-182.
  • 5徐礼燊 沙世炎.中草药有效成分分析法(下册)[M].北京:人民卫生出版社,1984.301-304.
  • 6李洪刚 何福江.甜菊甙的新提取法[J].甘肃医药,1986,5(1):46-46.
  • 7[1]Kuipers EJ.Review article:exploring the link between Helicobacter pylori and gastric cancer.Aliment Pharmacol Ther 1999; 13 Suppl 1:3-11
  • 8[2]Bazzoli F,Zagari RM,Fossi S.Short-term low dose triple therapy for the eradication of Helicobacter pylori.Eu J Gastroenterol Hepatol 1994; 6:773-777
  • 9[3]Lamouliatte H,Cayla R,Talbi P,Zerbib F,Megraud F.Randomised study comparing two seven days triple therapies with lansoprazole and low dose of clarithromycin plus Amoxycillin or tinidazole for Helicobacter pylori eradication.Gastroenterol 1996; 110:A170
  • 10[4]Lind T,Veldhuyzen van Zanten S,Unge P,Spiller R,Bayerdorffer E,O'Morain C,Bardhan KD,Bradette M,Chiba N,Wrangstadh M,Cederberg C,Idstrom JP.Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials:the MACH I Study.Helicobacter 1996; 1:138-144

共引文献227

同被引文献168

引证文献13

二级引证文献84

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部